Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForesight Envr Regulatory News (FGEN)

Share Price Information for Foresight Envr (FGEN)

Share Price is delayed by 15 minutes
Get Live Data
84.40    0.60 (0.72%)
Bid:
83.30
Ask:
84.30
Spread: 1.00 (1.20%)
Market Cap: £526.10m
FGEN Live PriceLast checked at - London Stock Exchange

Intraday Foresight Envr Share Chart

Total Voting Rights

2 Jan 2025 09:23

RNS Number : 9042R
Foresight Environmental Infrastruct
02 January 2025
Β 

Foresight Environmental Infrastructure Limited

("FGEN" or the "Company")

Β 

Total Voting Rights

Β 

The Board of FGEN announces that following the share buybacks into treasury inΒ DecemberΒ 2024, the Company's total shares in issue amounts to 647,077,087 as at 31 December 2024.

Β 

Following the transactions in December 2024, the Company's issued share capital comprises:

Β 

647,077,087 shares (excluding treasury shares)

Β 

14,454,142 shares held in treasury

Β 

661,531,229 shares (including treasury shares)

Β 

The Company has 647,077,087 ordinary shares with voting rights in issue. The above figure (647,077,087) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Β 

Β 

For further information, please contact:Β 

Β 

Foresight Group

ChrisΒ Tanner

Edward Mountney

Wilna de Villiers

+44(0)20 3667 8100

institutionalir@foresightgroup.eu

Β 

Β 

Winterflood Securities Limited

Neil Langford

Β 

Β +44(0)20 3100 0000

Β 

SEC Newgate

Elisabeth Cowell

Alice Cho

Harry Handyside

Β 

+44 (0)20 3757 6882

Apex Fund and Corporate Services (Guernsey) Limited

Matt Lihou

Matt Falla

Β 

+44(0)20 3530 3600

Β 

Β 

About FGEN

FGEN's investment policy is to invest in a diversified portfolio of Environmental Infrastructure. Environmental Infrastructure is defined by the Company as infrastructure assets, projects and asset-backed businesses that utilise natural or waste resources or support more environmentally friendly approaches to economic activity, support the transition to a low carbon economy or which mitigate the effects of climate change. Such investments will typically feature one or more of the following characteristics:

Β 

Β· long-term, predictable cash flows, which may be wholly or partially inflation-linked cash flows;

Β· long-term contracts or stable and well-proven regulatory and legal frameworks; or

Β· well-established technologies, and demonstrable operational performance

Β 

FGEN's aim is to provide investors with a sustainable, progressive dividend per share, paid quarterly and to preserve the capital value of the portfolio over the long term on a real basis. The target dividend for the year to 31 March 2025 is 7.80 pence per shareΒΉ. The dividend is payable quarterly.

Β 

FGEN is an Article 9 fund under the EU Sustainable Finance Disclosure Regulation and has a transparent and award winning approach to ESG.

Β 

Further details of the Company can be found on its website www.fgen.com

Β 

LEI: 213800JWJN54TFBMBI68

Β 

(1) These are targets only and not profit forecasts. There can be no assurance that these targets will be met or that the Company will make any distributions at all.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TVRSSUSUEEISEFF
Date   Source Headline
18th Jun 20267:04 amRNSBoard Changes
18th Jun 20267:00 amRNSAnnual Report for the Year Ended 31 March 2026
27th May 20267:01 amRNSNotice of Results
27th May 20267:00 amRNSNet Asset Value and Dividend Announcement
20th May 20267:00 amRNSDirector/PDMR Shareholding
12th May 20267:00 amRNSCapital Markets Day
22nd Apr 202612:47 pmRNSExtension of revolving credit facility
27th Feb 20267:00 amRNSDirector/PDMR Dealing
25th Feb 20267:00 amRNSNet Asset Value and Dividend Announcement
7th Jan 20264:37 pmRNS-RUpdate from QuotedData
28th Nov 20257:00 amRNSHalf-Year Report
19th Nov 20257:00 amRNSDividend Declaration
14th Nov 20257:00 amRNSPotential Impact of UK RO and FiT Consultation
3rd Nov 20257:00 amRNSNotice of Interim Results
1st Oct 20253:14 pmRNSTotal Voting Rights
1st Oct 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
26th Sep 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
23rd Sep 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Sep 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
18th Sep 202512:32 pmRNSResults of AGM
18th Sep 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Sep 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Sep 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Sep 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
12th Sep 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Sep 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
10th Sep 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
9th Sep 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Sep 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
5th Sep 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Sep 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
3rd Sep 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd Sep 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
1st Sep 20251:14 pmRNSTotal Voting Rights
1st Sep 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
29th Aug 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
28th Aug 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Aug 20257:00 amRNSBattery Portfolio Update
27th Aug 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
26th Aug 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
22nd Aug 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Aug 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
18th Aug 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Aug 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
13th Aug 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
12th Aug 20257:00 amRNSNotice of Annual General Meeting
12th Aug 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
7th Aug 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Aug 20255:17 pmRNSTransaction in Own Shares and Total Voting Rights
6th Aug 20255:10 pmRNSDuplicate Announcement Removal

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.